Annual Report

Overview

The report presents Avalon Pharma's 2023 performance as a year of growth, with revenues of 338 million Saudi riyals and expanded manufacturing and production capabilities. It reports 567 total employees, including staff in Saudi Arabia and the UAE. The dedicated ESG section describes implemented environmental initiatives such as converting diesel generators to electricity and recycling chemicals and packaging papers, alongside social practices covering occupational safety, training, equal opportunities, localization, and employee health.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: Ends 31 December 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services